These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6062192)

  • 1. Serum ceruloplasmin levels in healthy persons and in certain pathologic conditions.
    Lyko J
    Acta Med Pol; 1967; 8(3):269-77. PubMed ID: 6062192
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma levels of ceruloplasmin and copper in children with hepatic damage].
    Larrain F; Urbina AM; Lorenzo C; Danus O
    Rev Chil Pediatr; 1975; 46(4):351-5. PubMed ID: 1233556
    [No Abstract]   [Full Text] [Related]  

  • 3. [Test of stimulation of ceruloplasmin activity and copper concentration as affected by diphenylhydantoin (phenytoin, TSC) in the diagnosis of hepatolenticular degeneration].
    Pakszys W; Ligezińska B; Szymański H
    Pol Tyg Lek; 1982 Nov; 37(45):1353-7. PubMed ID: 7163091
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fluctuating blood copper concentrations].
    Köbberling J
    Dtsch Med Wochenschr; 1995 Mar; 120(13):461-2. PubMed ID: 7712938
    [No Abstract]   [Full Text] [Related]  

  • 5. [Correlation between serum values of copper, ceruloplasmin, SMAO, SDAO, in health- subjects, in pregnant women and in some pathological conditions (author's transl)].
    Bombardieri G; Rossi L; Bevilacqua E; Fabiani S; Tettamanti P
    Quad Sclavo Diagn; 1976 Jun; 12(2):131-47. PubMed ID: 828961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ceruloplasmin in hepatolenticular degeneration and the effect of copper on oxidative activity of ceruloplasmin].
    Wald I; Galewicz A; Górska D
    Neurol Neurochir Pol; 1971; 5(5):622-9. PubMed ID: 4258660
    [No Abstract]   [Full Text] [Related]  

  • 7. Low ceruloplasmin in a patient with Niemann-Pick type C disease.
    Connemann BJ; Gahr M; Schmid M; Runz H; Freudenmann RW
    J Clin Neurosci; 2012 Apr; 19(4):620-1. PubMed ID: 22269206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fatty liver hepatitis].
    Seidler D
    Dtsch Med Wochenschr; 1997 Jun; 122(24):802-3. PubMed ID: 9229566
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of the blood serum from subjects with hepatolenticular degeneration on the ceruloplasmin activity in the serum of normal and schizophrenic subjects].
    Puzyński S; Kalinowski A
    Neurol Neurochir Psychiatr Pol; 1966 Aug; 16(8):885-90. PubMed ID: 5969522
    [No Abstract]   [Full Text] [Related]  

  • 10. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin.
    Wald I; Galewicz A; Górska D
    Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors influencing serum ceruloplasmin levels in normal individuals.
    Cox DW
    J Lab Clin Med; 1966 Dec; 68(6):893-904. PubMed ID: 5926186
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease].
    Kanai M; Nomoto S; Tsukagoshi H; Shindo M
    Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum antioxidant activity in normal and abnormal subjects.
    Cranfield LM; Gollan JL; White AG; Dormandy TL
    Ann Clin Biochem; 1979 Nov; 16(6):299-306. PubMed ID: 539789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the need of ceruloplasmin and serum copper analyses in the diagnosis of Wilson's disease].
    Nomoto S; Kanai M; Matsuda Y
    Rinsho Byori; 1974 Oct; 22(10 Suppl):190. PubMed ID: 4475792
    [No Abstract]   [Full Text] [Related]  

  • 15. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 16. Copper distribution among serum proteins in paediatric liver disorders and malignancies.
    Barrow L; Tanner MS
    Eur J Clin Invest; 1988 Dec; 18(6):555-60. PubMed ID: 3147183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
    MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
    [No Abstract]   [Full Text] [Related]  

  • 18. Automated measurement of serum ferroxidase activity.
    Erel O
    Clin Chem; 1998 Nov; 44(11):2313-9. PubMed ID: 9799759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The copper hypothesis of schizophrenia: a review.
    Bowman MB; Lewis MS
    Neurosci Biobehav Rev; 1982; 6(3):321-8. PubMed ID: 7177508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathobiochemistry of Wilson's disease].
    Biesold D; Lössner J; Bachmann H; Zotter J
    Z Med Lab Diagn; 1982 Oct; 23(5):278-84. PubMed ID: 7180077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.